A Significant Growth Driver for the Stem Cell Therapy For Infertility Market Is the Surge In Infertility Cases Fueling Growth Due To Delayed Childbearing And Increasing Demand For Advanced Fertility Treatments

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Stem Cell Therapy For Infertility Market At The End Of The 2026–2030 Forecast Period?

The stem cell therapy for infertility market size has experienced rapid growth in recent years. It is projected to expand from $1.87 billion in 2025 to $2.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.6%. Historically, this growth has been influenced by the increasing prevalence of infertility conditions, the global expansion of fertility clinics, advancements in reproductive biology research, a rising demand for alternative infertility treatments, and the broader application of assisted reproductive procedures.

The stem cell therapy for infertility market is anticipated to experience significant expansion over the coming years. Projections indicate it will reach $3.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This projected growth is driven by several factors, including the increasing clinical validation of stem cell treatments for infertility, a rise in investments dedicated to reproductive regenerative medicine, broader acceptance of personalized fertility solutions, the expansion of clinical trials in reproductive health, and enhanced collaboration between fertility clinics and research institutions. Key trends anticipated during this period encompass a heightened focus on therapies for ovarian and testicular regeneration, a rise in the application of autologous stem cell treatments, growing integration with assisted reproductive technologies, the expansion of personalized fertility treatment protocols, and intensified clinical research within reproductive regeneration.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30408&type=smp

What Primary Drivers Are Shaping The Development Of The Stem Cell Therapy For Infertility Market?

The increasing instances of infertility are anticipated to significantly contribute to the future expansion of the stem cell therapy for infertility market. Infertility is defined as a couple’s inability to achieve pregnancy following 12 months or longer of consistent unprotected sexual activity. This growing incidence of infertility is primarily linked to delayed parenthood, as a significant number of people opt to start families later, leading to a decrease in fertility stemming from the natural age-related reduction in reproductive capability, especially for women. Stem cell therapy for infertility presents encouraging solutions through the regeneration of impaired reproductive tissues, enhancement of ovarian and testicular functionality, and an improved likelihood of conception. As an illustration, a report released by the World Health Organization (WHO), a Switzerland-based intergovernmental body, in April 2023, indicated that roughly 17.5% of adults worldwide, or about 1 in 6 individuals, are impacted by infertility, underscoring the increasing demand for broader access to economical and high-standard fertility treatment. Consequently, the increasing prevalence of infertility is expected to propel the growth of the stem cell therapy for infertility market.

What Segment Types Make Up The Stem Cell Therapy For Infertility Market?

The stem cell therapy for infertility market covered in this report is segmented –

1) By Type: Male Infertility Treatment, Female Infertility Treatment

2) By Treatment Type: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy, Combination Therapy

3) By Cell Source: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells

4) By Application: Ovarian Insufficiency, Uterine Infertility, Genetic Disorders

5) By End User: Hospitals, Specialty Clinics, Research Institutes

Subsegments:

1) By Male Infertility Treatment: Surgical Sperm Retrieval, Hormonal Therapy, Stem Cell Transplantation, Assisted Reproductive Techniques

2) By Female Infertility Treatment: Ovarian Stem Cell Therapy, Endometrial Regeneration Therapy, Hormonal Therapy, In Vitro Fertilization Enhancement

How Are Trends Transforming The Stem Cell Therapy For Infertility Market Landscape?

Leading companies in the stem cell therapy for infertility market are concentrating on advancements in stem cell technologies, particularly induced pluripotent stem cells (iPSCs), with the goal of enhancing personalized regenerative treatments, improving patient outcomes, and expanding the spectrum of treatable reproductive conditions. Induced pluripotent stem cells are adult somatic cells that have been genetically reprogrammed to achieve an embryonic-like pluripotent state, enabling them to differentiate into almost any cell type within the body. For instance, in January 2025, Gameto Inc., a US-based biotechnology company, commenced a pivotal Phase III clinical trial for its iPSC-derived fertility therapy, Fertilo, following the Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA). This trial, involving approximately 15 sites across the U.S., seeks to evaluate egg maturation outside the body utilizing engineered ovarian support cells, potentially shortening IVF cycles and reducing hormonal stimulation by up to 80%. If proven successful, this would constitute the inaugural late-stage clinical program for an in-vitro matured egg therapy, derived from induced pluripotent stem cells, aimed at treating infertility.

Who Are The Key Players Driving Competition In The Stem Cell Therapy For Infertility Market?

Major companies operating in the stem cell therapy for infertility market are PlacidWay LLC, New Life India Fertility Clinic Private Limited, Jeevan Mithra Fertility Centre Private Limited, Equipo IVI S.L., Hope Fertility & Stem Cell Centre Pvt. Ltd., Bioscience Institute SpA, Advancells Dermaceuticals Private Limited, GIOSTAR INDIA PRIVATE LIMITED, Shree IVF Clinic Private Limited, Stem Cells Care (india) Private Limited, GenCell Ltd., StemRx BioScience Solutions Private Limited., Kiran Infertility Centre Private Limited, R3 Stem Cell LLC., Bavishi Fertility Institute Private Limited, Seragen Biotherapeutics Private Limited, Esha IVF Fertility Centre Private Limited, Embryonic Tissue Center EmCell, InoCells B.V., Vega Stem Cell Clinic Co. Ltd.

Read the full stem cell therapy for infertility market report here:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-therapy-for-infertility-market-report

How Does The Stem Cell Therapy For Infertility Market Perform Across Major Global Regions?

North America was the largest region in the stem cell therapy for infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Stem Cell Therapy For Infertility Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30408&type=smp

Browse Through More Reports Similar to the Global Stem Cell Therapy For Infertility Market 2026, By The Business Research Company

Stem Cells Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Fertility Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Fertility Treatments Global Market Report

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795